Detalles de la búsqueda
1.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis
; 228(3): 235-244, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883903
2.
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
MMWR Morb Mortal Wkly Rep
; 72(17): 463-468, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104244
3.
Determinants of Professional Fulfillment and Burnout Among Intensivists: A National Survey by the Society of Critical Care Anesthesiologists in 2022.
Anesth Analg
; 137(2): 375-382, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791019
4.
Nationwide Clinical Practice Patterns of Anesthesiology Critical Care Physicians: A Survey to Members of the Society of Critical Care Anesthesiologists.
Anesth Analg
; 136(2): 295-307, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950751
5.
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
Am J Respir Crit Care Med
; 206(6): 730-739, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580040
6.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
J Infect Dis
; 226(5): 797-807, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385875
7.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
8.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
9.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
10.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1625-1630, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580424
11.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
12.
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(12): 459-465, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324878
13.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
14.
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
BMC Infect Dis
; 22(1): 818, 2022 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344927
15.
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
Clin Infect Dis
; 73(Suppl 1): S32-S37, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977301
16.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956782
17.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
18.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524
19.
Characteristics and Outcomes of Mechanically Ventilated COVID-19 Patients-An Observational Cohort Study.
J Intensive Care Med
; 36(3): 271-276, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32873103
20.
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA
; 326(20): 2043-2054, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734975